Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.27 USD | +2.62% | +3.81% | -8.20% |
16/05 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
02/05 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
274M | - | - | - | |||
223B | ||||||
195B | ||||||
144B | ||||||
111B | ||||||
65.01B |
- Stock Market
- Equities
- AXGN Stock
- Charts AxoGen, Inc.
- Sector Chart